These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

197 related items for PubMed ID: 21803956

  • 21. Malignant fibrous histiocytoma: Database review suggests a favorable prognosis in the head and neck.
    Borucki RB, Neskey DM, Lentsch EJ.
    Laryngoscope; 2018 Apr; 128(4):885-888. PubMed ID: 28988458
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Evidence for an association between cutaneous malignant melanoma and lymphoid malignancy: a population-based retrospective cohort study in Scotland.
    McKenna DB, Stockton D, Brewster DH, Doherty VR.
    Br J Cancer; 2003 Jan 13; 88(1):74-8. PubMed ID: 12556962
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Prediagnostic immunoglobulin E levels and risk of chronic lymphocytic leukemia, other lymphomas and multiple myeloma-results of the European Prospective Investigation into Cancer and Nutrition.
    Nieters A, Łuczyńska A, Becker S, Becker N, Vermeulen R, Overvad K, Aleksandrova K, Boeing H, Lagiou P, Trichopoulos D, Trichopoulou A, Krogh V, Masala G, Panico S, Tumino R, Sacerdote C, Bueno-de-Mesquita B, Jeurnink SM, Weiderpass E, Ardanaz E, Chirlaque MD, Sánchez MJ, Sánchez S, Borgquist S, Butt S, Melin B, Späth F, Rinaldi S, Brennan P, Kelly RS, Riboli E, Vineis P, Kaaks R.
    Carcinogenesis; 2014 Dec 13; 35(12):2716-22. PubMed ID: 25269801
    [Abstract] [Full Text] [Related]

  • 27. Occupation and risk of non-Hodgkin's lymphoma and chronic lymphocytic leukemia.
    Zheng T, Blair A, Zhang Y, Weisenburger DD, Zahm SH.
    J Occup Environ Med; 2002 May 13; 44(5):469-74. PubMed ID: 12024692
    [Abstract] [Full Text] [Related]

  • 28. Association of advanced leukemic stage and skin cancer tumor stage with poor skin cancer outcomes in patients with chronic lymphocytic leukemia.
    Velez NF, Karia PS, Vartanov AR, Davids MS, Brown JR, Schmults CD.
    JAMA Dermatol; 2014 Mar 13; 150(3):280-7. PubMed ID: 24429548
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Risk factors associated with Richter's transformation in patients with chronic lymphocytic leukaemia: protocol for a retrospective population-based cohort study.
    Hleuhel MH, Ben-Dali Y, Da Cunha-Bang C, Brieghel C, Clasen-Linde E, Niemann CU, Andersen MA.
    BMJ Open; 2019 Mar 03; 9(3):e023566. PubMed ID: 30833314
    [Abstract] [Full Text] [Related]

  • 31. Malignant fibrous histiocytoma of bone: A survival analysis from the National Cancer Database.
    Malik AT, Baek J, Alexander JH, Voskuil RT, Khan SN, Scharschmidt TJ.
    J Surg Oncol; 2020 Jun 03; 121(7):1097-1103. PubMed ID: 32133661
    [Abstract] [Full Text] [Related]

  • 32. Epidemiologic and Clinical Patterns of Malignant Lymphoma in Qatar 2013-2017: A Population-Based Cohort Study.
    Adel AM, Exarchakou A, Elshafey N, Ghazouani H, Alshurafa A, Yassin MA.
    Oncology; 2024 Jun 03; 102(9):800-809. PubMed ID: 38320544
    [Abstract] [Full Text] [Related]

  • 33. An increased risk of non-Hodgkin lymphoma and chronic lymphocytic leukemia in US patients with Merkel cell carcinoma versus Australian patients: A clinical clue to a different mechanism of pathogenesis?
    Bloom R, Amber KT, Nouri K.
    Australas J Dermatol; 2016 Aug 03; 57(3):e114-6. PubMed ID: 25801041
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. MFH of bone and osteosarcoma show similar survival and chemosensitivity.
    Jeon DG, Song WS, Kong CB, Kim JR, Lee SY.
    Clin Orthop Relat Res; 2011 Feb 03; 469(2):584-90. PubMed ID: 20559764
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Racial differences in three major NHL subtypes: descriptive epidemiology.
    Li Y, Wang Y, Wang Z, Yi D, Ma S.
    Cancer Epidemiol; 2015 Feb 03; 39(1):8-13. PubMed ID: 25560974
    [Abstract] [Full Text] [Related]

  • 38. Medical history, lifestyle, family history, and occupational risk factors for chronic lymphocytic leukemia/small lymphocytic lymphoma: the InterLymph Non-Hodgkin Lymphoma Subtypes Project.
    Slager SL, Benavente Y, Blair A, Vermeulen R, Cerhan JR, Costantini AS, Monnereau A, Nieters A, Clavel J, Call TG, Maynadié M, Lan Q, Clarke CA, Lightfoot T, Norman AD, Sampson JN, Casabonne D, Cocco P, de Sanjosé S.
    J Natl Cancer Inst Monogr; 2014 Aug 03; 2014(48):41-51. PubMed ID: 25174025
    [Abstract] [Full Text] [Related]

  • 39. Frequency and impact of grade three or four toxicities of novel agents on outcomes of older patients with chronic lymphocytic leukemia and non-Hodgkin lymphoma (alliance A151611).
    Tallarico M, Foster JC, Seisler D, Lafky JM, Hurria A, Jatoi A, Cohen HJ, Muss HB, Bartlett N, Cheson BD, Jung SH, Leonard JP, Byrd JC, Nabhan C.
    J Geriatr Oncol; 2018 Jul 03; 9(4):321-328. PubMed ID: 29673807
    [Abstract] [Full Text] [Related]

  • 40. Statin use and survival in 16 098 patients with non-Hodgkin lymphoma or chronic lymphocytic leukaemia treated in the rituximab era.
    Brånvall E, Ekberg S, Eloranta S, Wästerlid T, Birmann BM, Smedby KE.
    Br J Haematol; 2021 Nov 03; 195(4):552-560. PubMed ID: 34331461
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.